Metropolis Healthcare informs about updates

05 Jan 2026 Evaluate

In accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Code of Fair Disclosure of Unpublished Price Sensitive Information & Policy for Legitimate Purpose in terms of Regulation 8 of the SEBI (Prohibition of Insider Trading) Regulations, 2015, Metropolis Healthcare has informed that the Company has provided a business update for the quarter ended December 31, 2025. This update seeks to provide an overall summary of the operating performance and demand trends witnessed during the quarter ended December 31, 2025. A detailed information update will follow once the Board of Directors approve the financial results for Q3FY26. The company delivered a strong 26% year-on-year consolidated revenue growth, driven by sustained momentum in preventive and wellness health check-ups under TruHealth, along with a strong increase in specialty testing volumes across both B2C and B2B channels. Supported by an expanded Core Diagnostics test menu for high-end specialty testing and continuous in-house innovation, the company has successfully scaled its specialty business across its pan-India network.

The above information is a part of company’s filings submitted to BSE.


Metropolis Health. Share Price

2024.90 -26.20 (-1.28%)
06-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7347.85
Max Healthcare Inst 1051.65
Narayana Hrudayalay 1936.70
Aster DM Healthcare 626.10
Global Health 1210.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×